Boston, MA -- (SBWIRE) -- 01/19/2017 -- Respiratory syncytial virus (RSV) is a virus that leads to infections in the lungs and the respiratory tract. It commonly affects most children in the ages 2 or below. RSV can also infect adults. In adults and the older population, the symptoms of RSV are mild and similar to that of common cold. Infection with RSV can be severe in certain cases, particularly in premature infants and babies with underlying health conditions. RSV can also become serious in the older population or adults with heart and lung diseases, or any individual with a very weak immune system.

Technavio's analysts forecast the global human respiratory syncytial virus drugs market to grow at a CAGR of 4.27% during the period 2016-2020.

Get More Details on this Report and a Full Table of Contents at Global Human Respiratory Syncytial Virus Drugs Market 2016-2020

Covered in this report

The report covers the present scenario and the growth prospects of the global human respiratory syncytial virus drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent respiratory syncytial virus infections.

The market is divided into the following segments based on geography:

-Europe
-ROW
-US

Technavio's report, Global Human Respiratory Syncytial Virus Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AstraZeneca
-AbbVie
-GSK
-Teva Pharmaceutical

Other prominent vendors

-Ablynx
-ADMA Biologics
-Alnylam Pharmaceuticals
-Ark Biosciences
-Aviragen Therapeutics
-Bavarian Nordic
-Boehringer Ingelheim
-Gilead Sciences
-ImmunoVaccine Technologies
-Johnson & Johnson
-Kyowa Hakko Kirin
-Medivir
-Mucosis
-Mymetics Corporation
-Novavax
-Regeneron Pharmaceuticals
-ReViral
-Vaxart

Market driver

-Novel diagnostic tools increase patient population.
-For a full, detailed list, view our report

Market challenge

-Continuous change in guidelines from healthcare organizations impacts market growth.
-For a full, detailed list, view our report

Market trend

-Emergence of new entrants likely to change market dynamics.
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Other Prominent Vendors in the market are: Askon Engineers, Bio JetDrier, HOKWANG INDUSTRIES, Taishan Jieda Electrical Industrial, Panasonic,, Palmer Fixture

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:
-Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2015
-Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2016
-Respiratory Syncytial Virus Fusion Protein (RSV-F Protein) - Pipeline Review, H1 2016
-Global Metabolic Disorders Therapeutics Market 2016-2020
-Respiratory Syncytial Virus Attachment Glycoprotein (G or RSV-G) - Pipeline Review, H1 2016